Designed Peptide P21 Boosts Memory and Grows New Brain Cells in Normal Mice

A small designed peptide called P21 that mimics brain growth factors improved learning and memory in normal mice and stimulated new neuron growth in the hippocampus when given peripherally.

Li, Bin et al.·FEBS letters·2010·earlyanimal
RPEP-01648Animalearly2010RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal
Evidence
early
Sample
Normal adult C57Bl6 mice
Participants
Normal adult C57Bl6 mice

What This Study Found

A designed peptide called P21 (Ac-DGGLAG-NH2), incorporating adamantane to improve brain penetration, enhanced learning, short-term memory, and spatial reference memory in normal adult mice when given peripherally (not requiring brain injection). P21 also stimulated neurogenesis — the birth of new neurons — and promoted their maturation into functional neurons in the dentate gyrus of the hippocampus, the brain region critical for memory formation.

Key Numbers

P21: 6 amino acids (Ac-DGGLAG-NH2) · Enhanced learning + short-term + spatial memory · Increased neurogenesis in dentate gyrus · Peripheral administration · Normal adult C57Bl6 mice

How They Did This

P21 peptide was designed incorporating adamantane moiety for improved brain penetration. Normal adult C57Bl6 mice received peripheral P21 administration and were tested for learning and memory using behavioral assays. Neurogenesis was assessed by examining the granular cell layer and subgranular zone of the dentate gyrus for new neuron birth and maturation.

Why This Research Matters

Neurotrophins like BDNF and CNTF are powerful brain growth factors that promote neuron survival and new neuron growth, but they're too large to cross the blood-brain barrier as drugs. P21 was designed as a small peptide that mimics neurotrophin effects while being small enough to reach the brain from a peripheral injection. The fact that it enhanced cognition in normal (not diseased) mice suggests potential applications beyond Alzheimer's disease.

The Bigger Picture

The challenge of getting therapeutic peptides into the brain is one of the biggest barriers in neurology. P21 represents a creative solution: instead of trying to deliver large neurotrophins across the blood-brain barrier, design a small peptide that mimics their effects and use chemical modifications (adamantane) to improve brain penetration. This approach has broader implications for treating neurodegenerative diseases where neurotrophin signaling is impaired.

What This Study Doesn't Tell Us

Mouse study in normal (non-diseased) animals — effects in Alzheimer's models or humans are unknown. The specific dose, route, and duration of P21 treatment are not detailed in the abstract. Long-term safety of promoting neurogenesis is not addressed. No comparison to existing cognitive enhancers.

Questions This Raises

  • ?Does P21 show similar memory-enhancing and neurogenic effects in Alzheimer's disease mouse models?
  • ?What is the long-term safety profile of peptide-induced neurogenesis — could stimulating new neuron growth have unintended consequences?
  • ?How does the adamantane modification specifically improve brain penetration, and could this strategy be applied to other therapeutic peptides?

Trust & Context

Key Stat:
Peripheral injection → new brain neurons The small peptide P21 was given by peripheral injection yet stimulated neurogenesis and neuron maturation in the hippocampus, demonstrating brain penetration
Evidence Grade:
This is an early-stage animal study in normal mice. While the combination of behavioral and histological evidence is encouraging, it represents initial proof-of-concept in a non-disease model with an undefined dose and route.
Study Age:
Published in 2010 by researchers at the New York State Institute for Basic Research in Developmental Disabilities. P21 has been studied in subsequent publications but has not advanced to clinical trials as of the mid-2020s.
Original Title:
Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice.
Published In:
FEBS letters, 584(15), 3359-65 (2010)
Database ID:
RPEP-01648

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is neurogenesis and why is it important for memory?

Neurogenesis is the birth of new neurons in the brain. In adults, it mainly occurs in the hippocampus — the brain region essential for forming new memories. Stimulating neurogenesis could help replace lost neurons in diseases like Alzheimer's or enhance cognitive function in healthy aging.

What is adamantane and why was it added to this peptide?

Adamantane is a small, cage-shaped carbon molecule that makes compounds more fat-soluble. Since the blood-brain barrier blocks most water-soluble molecules, attaching adamantane to the peptide P21 helps it cross from the bloodstream into the brain. It's the same chemical scaffold used in the antiviral drug amantadine.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01648·https://rethinkpeptides.com/research/RPEP-01648

APA

Li, Bin; Wanka, Lukas; Blanchard, Julie; Liu, Fei; Chohan, Muhammad Omar; Iqbal, Khalid; Grundke-Iqbal, Inge. (2010). Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice.. FEBS letters, 584(15), 3359-65. https://doi.org/10.1016/j.febslet.2010.06.025

MLA

Li, Bin, et al. "Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice.." FEBS letters, 2010. https://doi.org/10.1016/j.febslet.2010.06.025

RethinkPeptides

RethinkPeptides Research Database. "Neurotrophic peptides incorporating adamantane improve learn..." RPEP-01648. Retrieved from https://rethinkpeptides.com/research/li-2010-neurotrophic-peptides-incorporating-adamantane

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.